TABLE 3.
Pharmacokinetic parameters of five components in MA rats (n = 6), *P < 0.05 vs. GBT.
| Compound | Group | Cmax/ng·mL-1 | Tmax/h | T1/2/h | AUC0-t/ng•h•mL-1 |
|---|---|---|---|---|---|
| Paeoniflorin | GBT | 183.9 ± 34.59 | 0.93 ± 0.15 | 10.89 ± 8.82 | 930.99 ± 198.80 |
| GBT-S | 203.4 ± 87.91 | 1.60 ± 0.55 | 12.08 ± 10.21 | 1294.37 ± 622.39 | |
| GBT-C | 189.33 ± 124.88 | 1.61 ± 1.25 | 12.71 ± 17.38 | 1106.22 ± 879.41 | |
| GBT-D | 209.17 ± 84.37 | 1.11 ± 0.46 | 4.21 ± 3.03 | 709.88 ± 311.29 | |
| Liquiritin | GBT | 27.02 ± 14.39 | 0.37 ± 0.36 | 6.58 ± 4.47 | 66.89 ± 26.41 |
| GBT-S | 30.15 ± 18.93 | 1.19 ± 0.70* | 11.54 ± 13.19 | 117.12 ± 87.93 | |
| Glycyrrhizic acid | GBT | 49.34 ± 17.66 | 10.00 ± 8.49 | 17.97 ± 14.96 | 780.03 ± 368.48 |
| GBT-S | 88.75 ± 29.60* | 6.72 ± 8.87 | 9.87 ± 2.12 | 1026.32 ± 613.11 | |
| Glycyrrhetinic acid | GBT | 696.9 ± 235.39 | 21.60 ± 5.37 | 10,936.175 ± 5,404.52 | |
| GBT-S | 303.83 ± 188.81* | 16.33 ± 8.62 | 5,273.19 ± 3,556.06 | ||
| Kansuinine A | GBT | 0.00 ± 0.00 | 0.00 ± 0.00 | 0.00 ± 0.00 | |
| GBT-C | 1.58 ± 1.14* | 5.29 ± 5.61 | 14.55 ± 2.35 |